Comparison of Once Daily Fluticasone Furoate/Vilanterol With Twice Daily Fluticasone Propionate/Salmeterol in Patients With Controlled Asthma

被引：2
|
作者：
Bernstein, David
Forth, Richard
Yates, Louisa
Andersen, Leslie
Jacques, Loretta
机构：
[1] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[2] Bernstein Clin Res Ctr, Cincinnati, OH USA
来源：
CHEST | 2017年 / 152卷 / 04期
关键词：
D O I：
10.1016/j.chest.2017.08.217
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：186A / 186A
页数：1
相关论文
共 50 条
  • [1] Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA
    Bernstein, David
    Andersen, Leslie
    Forth, Richard
    Jacques, Loretta
    Yates, Louisa
    JOURNAL OF ASTHMA, 2018, 55 (09) : 984 - 993
  • [2] ADHERENCE WITH ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL COMPARED TO TWICE-DAILY BUDESONIDE/FORMOTEROL OR FLUTICASONE PROPIONATE/SALMETEROL IN ASTHMA
    Averell, C.
    Stanford, R.
    Laliberte, F.
    Wu, J.
    Germain, G.
    Duh, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S39 - S39
  • [3] A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD
    Agusti, Alvar
    de Teresa, Luis
    De Backer, Wilfried
    Zvarich, Michael T.
    Locantore, Nicholas
    Barnes, Neil
    Bourbeau, Jean
    Crim, Courtney
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (03) : 763 - 772
  • [4] Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database
    Atsuta R.
    Takai J.
    Mukai I.
    Kobayashi A.
    Ishii T.
    Svedsater H.
    Pulmonary Therapy, 2018, 4 (2) : 135 - 147
  • [5] A Comparison of the Efficacy of Once-Daily Fluticasone Furoate/Vilanterole with Twice-Daily Fluticasone Propionate/Salmeterol in Elderly Asthmatics
    Ishiura, Yoshihisa
    Fujimura, Masaki
    Shiba, Yasutaka
    Ohkura, Noriyuki
    Hara, Johsuke
    Abo, Miki
    Kasahara, Kazuo
    DRUG RESEARCH, 2018, 68 (01) : 38 - 44
  • [6] A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-daily fluticasone propionate/salmeterol in asthma-COPD overlap syndrome
    Ishiura, Yoshihisa
    Fujimura, Masaki
    Shiba, Yasutaka
    Ohkura, Noriyuki
    Hara, Johsuke
    Kasahara, Kazuo
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 35 : 28 - 33
  • [7] Once-daily fluticasone furoate/vilanterol vs once-daily fluticasone furoate in patients with asthma aged 5 to 17 years
    Bareille, Philippe
    Forth, Richard
    Imber, Varsha
    Bondarenko, Irina
    Michaud, Arthur
    Majorek-Olechowska, Bernadetta
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (05)
  • [8] Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
    Dransfield, Mark T.
    Feldman, Gregory
    Korenblat, Phillip
    LaForce, Craig F.
    Locantore, Nicholas
    Pistolesi, Massimo
    Watkins, Michael L.
    Crim, Courtney
    Martinez, Fernando J.
    RESPIRATORY MEDICINE, 2014, 108 (08) : 1171 - 1179
  • [9] Salmeterol/fluticasone propionate via Diskus™ once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids
    Chuchalin, Alexander
    Jacques, Loretta
    Frith, Lucy
    CLINICAL DRUG INVESTIGATION, 2008, 28 (03) : 169 - 181
  • [10] Salmeterol/Fluticasone Propionate via Diskus™ Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids
    Alexander Chuchalin
    Loretta Jacques
    Lucy Frith
    Clinical Drug Investigation, 2008, 28 : 169 - 181
12345